Literature DB >> 15630155

New approaches for treatment of peanut allergy: chances for a cure.

Wesley Burks1, Samuel B Lehrer, Gary A Bannon.   

Abstract

Food allergy is a major cause of life-threatening hypersensitive reactions. Food-induced anaphylaxis is the most common reason for a person to present to the emergency department for treatment of the anaphylactic reaction. Avoiding the allergenic food is the only currently available method for sensitized patients to prevent further reactions. Strict avoidance of specific foods is accepted treatment of food-induced allergic reactions but is often an unrealistic therapeutic strategy for the treatment and prevention of food-induced hypersensivity reactions for the many reasons. Desirable therapeutic strategies for the treatment and prevention of the food allergies must be safe, relatively inexpensive, and easily administered. Recent advances in the understanding of the immunological mechanisms underlying allergic disease and better characterization of food allergens have greatly expanded the potential therapeutic option for future use. Several different forms of immunodulatory therapies are currently under investigation: peptide immunotherapy, mutated protein immunotherapy, allergen DNA immunization, vaccination with immunostimulatory DNA sequences, and anti-immunoglobulin E-therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15630155     DOI: 10.1385/CRIAI:27:3:191

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  21 in total

1.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

2.  Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.

Authors:  S S Saini; D W MacGlashan; S A Sterbinsky; A Togias; D C Adelman; L M Lichtenstein; B S Bochner
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

3.  Effects of birch pollen SIT on apple allergy: a matter of dosage?

Authors:  R Asero
Journal:  Allergy       Date:  2004-12       Impact factor: 13.146

4.  A DNA vaccine for allergen immunotherapy using the latex allergen Hev b 5.

Authors:  J E Slater; A Colberg-Poley
Journal:  Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M       Date:  1997

5.  Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2.

Authors:  J S Stanley; N King; A W Burks; S K Huang; H Sampson; G Cockrell; R M Helm; C M West; G A Bannon
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

6.  Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model.

Authors:  Xiu-Min Li; Kamal Srivastava; James W Huleatt; Kim Bottomly; A Wesley Burks; Hugh A Sampson
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

7.  Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization.

Authors:  C H Hsu; K Y Chua; M H Tao; Y L Lai; H D Wu; S K Huang; K H Hsieh
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

8.  A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.

Authors:  X M Li; D Serebrisky; S Y Lee; C K Huang; L Bardina; B H Schofield; J S Stanley; A W Burks; G A Bannon; H A Sampson
Journal:  J Allergy Clin Immunol       Date:  2000-07       Impact factor: 10.793

9.  Treatment of cat allergy with T-cell reactive peptides.

Authors:  P S Norman; J L Ohman; A A Long; P S Creticos; M A Gefter; Z Shaked; R A Wood; P A Eggleston; K B Hafner; P Rao; L M Lichtenstein; N H Jones; C F Nicodemus
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

10.  Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients.

Authors:  R Asero
Journal:  Clin Exp Allergy       Date:  1998-11       Impact factor: 5.018

View more
  1 in total

1.  Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy.

Authors:  Weiqi Wang; Shu-Chen Lyu; Xuhuai Ji; Sheena Gupta; Monali Manohar; Gopal K R Dhondalay; Sharon Chinthrajah; Sandra Andorf; Scott D Boyd; Robert Tibshirani; Stephen J Galli; Kari C Nadeau; Holden T Maecker
Journal:  Clin Immunol       Date:  2020-08-09       Impact factor: 3.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.